Para-Fluorophenylpiperazine (original) (raw)
para-Fluorophenylpiperazine (pFPP, 4-FPP, 4-Fluorophenylpiperazine; Fluoperazine, Flipiperazine) is a piperazine derivative with mildly psychedelic and euphoriant effects. It has been sold as an ingredient in legal recreational drugs known as "Party pills", initially in New Zealand and subsequently in other countries around the world. pFPP has been found in vitro to act mainly as a 5-HT1A receptor agonist, with some additional affinity for the 5-HT2A and 5-HT2C receptors. It has also been shown to inhibit the reuptake of serotonin and norepinephrine, and to possibly induce their release.
| Property | Value |
|---|---|
| dbo:abstract | para-Fluorophenylpiperazine (pFPP, 4-FPP, 4-Fluorophenylpiperazine; Fluoperazine, Flipiperazine) is a piperazine derivative with mildly psychedelic and euphoriant effects. It has been sold as an ingredient in legal recreational drugs known as "Party pills", initially in New Zealand and subsequently in other countries around the world. pFPP has been found in vitro to act mainly as a 5-HT1A receptor agonist, with some additional affinity for the 5-HT2A and 5-HT2C receptors. It has also been shown to inhibit the reuptake of serotonin and norepinephrine, and to possibly induce their release. pFPP was originally discovered as a metabolite of the hypnotic 5-HT2A and α1-adrenergic receptor antagonist niaprazine in 1982, but was rediscovered in 2003 as a potential recreational drug, and sold as an ingredient in "Party pills" in New Zealand, under brand names such as "The Big Grin", "Mashed", and "Extreme Beans". Subsequently it has continued to be used as an ingredient in black market "ecstasy" pills around the world. pFPP has little stimulant effects, with its subjective effects derived mainly from its action as a 5-HT1A receptor agonist. pFPP is active at doses between 20 and 150 mg, but higher doses cause a range of side-effects such as migraine headaches, muscle aches, anxiety, nausea, and vomiting. Metabolic studies have shown pFPP to be an inhibitor of various Cytochrome P450 enzymes in the liver which may contribute to its side-effect profile. Based on the recommendation of the EACD, the New Zealand government has passed legislation which placed BZP, along with a number of other piperazine derivatives, into Class C of the New Zealand Misuse of Drugs Act 1975. A ban was intended to come into effect in New Zealand on December 18, 2007, but the law change did not go through until the following year, and the sale of BZP and the other listed piperazines became illegal in New Zealand as of 1 April 2008. An amnesty for possession and usage of these drugs remained until October 2008, at which point they became completely illegal. This drug has been detected in a drug-facilitated sexual assault case in the United States of America. (en) |
| dbo:casNumber | 2252-63-3 64090-19-3 |
| dbo:fdaUniiCode | VML61BE244 |
| dbo:pubchem | 75260 |
| dbo:thumbnail | wiki-commons:Special:FilePath/PFPP.svg?width=300 |
| dbo:wikiPageID | 9122224 (xsd:integer) |
| dbo:wikiPageLength | 5705 (xsd:nonNegativeInteger) |
| dbo:wikiPageRevisionID | 1100905103 (xsd:integer) |
| dbo:wikiPageWikiLink | dbr:Metabolite dbr:Party_pills dbr:Cytochrome_P450 dbr:In_vitro dbr:Reuptake_inhibitor dbr:Psychedelic_drug dbc:Designer_drugs dbc:Entactogens_and_empathogens dbc:Fluoroarenes dbc:Phenylpiperazines dbc:Psychedelic_drugs dbc:Serotonin_receptor_agonists dbr:Nausea dbr:Anxiety dbr:Receptor_antagonist dbr:Agonist dbr:5-HT2A_receptor dbc:Monoamine_releasing_agents dbr:Alpha-1_adrenergic_receptor dbr:Euphoriant dbr:Norepinephrine dbr:Vomiting dbr:Headache dbr:Recreational_drugs dbr:Piperazine dbr:Poland dbr:Migraine dbr:New_Zealand dbr:Niaprazine dbr:Serotonin dbr:Reuptake dbr:Substituted_piperazine dbr:Releasing_agent dbr:Muscle_ache dbr:5-HT1A dbr:5-HT2A dbr:5-HT2C |
| dbp:c | 10 (xsd:integer) |
| dbp:casNumber | 2252 (xsd:integer) 64090 (xsd:integer) |
| dbp:eliminationHalfLife | -28800.0 |
| dbp:excretion | Renal (en) |
| dbp:f | 1 (xsd:integer) |
| dbp:h | 13 (xsd:integer) |
| dbp:image | PFPP3d.png (en) |
| dbp:index2Label | dihydrochloride (en) |
| dbp:iupacName | 1 (xsd:integer) |
| dbp:legalDe | Anlage II (en) |
| dbp:legalNz | Class C (en) |
| dbp:legalStatus | II-P (en) |
| dbp:metabolism | Hepatic (en) |
| dbp:n | 2 (xsd:integer) |
| dbp:pubchem | 75260 (xsd:integer) |
| dbp:routesOfAdministration | Oral (en) |
| dbp:unii | VML61BE244 (en) |
| dbp:verifiedrevid | 447725945 (xsd:integer) |
| dbp:width | 150 (xsd:integer) |
| dbp:wikiPageUsesTemplate | dbt:Citation_needed dbt:Drugbox dbt:Entactogens dbt:Hallucinogens dbt:Monoamine_releasing_agents dbt:Piperazines dbt:Reflist dbt:Serotonin_receptor_modulators dbt:Short_description dbt:Cascite dbt:Fdacite |
| dcterms:subject | dbc:Designer_drugs dbc:Entactogens_and_empathogens dbc:Fluoroarenes dbc:Phenylpiperazines dbc:Psychedelic_drugs dbc:Serotonin_receptor_agonists dbc:Monoamine_releasing_agents |
| gold:hypernym | dbr:Piperazine |
| rdf:type | owl:Thing dul:ChemicalObject dbo:ChemicalSubstance wikidata:Q8386 yago:Agent114778436 yago:CausalAgent100007347 yago:DesignerDrug103179489 yago:Drug103247620 yago:Hallucinogen103479647 yago:Matter100020827 yago:Medicine103740161 yago:PhysicalEntity100001930 yago:Piperazine103946814 yago:PsychoactiveDrug104017137 dbo:Drug yago:Substance100020090 yago:Vermifuge104528630 yago:WikicatDesignerDrugs yago:WikicatPiperazines yago:WikicatPsychedelicDrugs umbel-rc:DrugProduct |
| rdfs:comment | para-Fluorophenylpiperazine (pFPP, 4-FPP, 4-Fluorophenylpiperazine; Fluoperazine, Flipiperazine) is a piperazine derivative with mildly psychedelic and euphoriant effects. It has been sold as an ingredient in legal recreational drugs known as "Party pills", initially in New Zealand and subsequently in other countries around the world. pFPP has been found in vitro to act mainly as a 5-HT1A receptor agonist, with some additional affinity for the 5-HT2A and 5-HT2C receptors. It has also been shown to inhibit the reuptake of serotonin and norepinephrine, and to possibly induce their release. (en) |
| rdfs:label | Para-Fluorophenylpiperazine (en) |
| owl:sameAs | freebase:Para-Fluorophenylpiperazine yago-res:Para-Fluorophenylpiperazine wikidata:Para-Fluorophenylpiperazine dbpedia-sh:Para-Fluorophenylpiperazine dbpedia-sr:Para-Fluorophenylpiperazine https://global.dbpedia.org/id/4t7Xn |
| prov:wasDerivedFrom | wikipedia-en:Para-Fluorophenylpiperazine?oldid=1100905103&ns=0 |
| foaf:depiction | wiki-commons:Special:FilePath/PFPP.svg wiki-commons:Special:FilePath/PFPP3d.png |
| foaf:isPrimaryTopicOf | wikipedia-en:Para-Fluorophenylpiperazine |
| is dbo:wikiPageRedirects of | dbr:C10H13FN2 dbr:Para-fluorophenylpiperazine dbr:PFPP dbr:Parafluorophenylpiperazine dbr:4-Fluorophenylpiperazine |
| is dbo:wikiPageWikiLink of | dbr:List_of_designer_drugs dbr:Presumption_of_supply_in_New_Zealand dbr:Monatepil dbr:C10H13FN2 dbr:Drugs_controlled_by_the_German_Betäubungsmittelgesetz dbr:Para-fluorophenylpiperazine dbr:PFPP dbr:Parafluorophenylpiperazine dbr:4-Fluorophenylpiperazine |
| is foaf:primaryTopic of | wikipedia-en:Para-Fluorophenylpiperazine |
